Free shipping on all orders over $ 500

Sonelokimab

Cat. No. M24655

All AbMole products are for research use only, cannot be used for human consumption.

Sonelokimab Structure
Synonym:

ALX 0761; M 1095

Size Price Availability Quantity
100ug USD 500 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?
Quality Control & Documentation
Biological Activity

Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F, and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research.

Chemical Information
CAS Number 1414386-05-2
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Sunil Dogra, et al. Expert Opin Biol Ther. Biological treatment for erythrodermic psoriasis

[2] Kristian Reich, et al. Br J Dermatol. Maintenance of response in moderate-to-severe psoriasis after withdrawal of the interleukin (IL)-17A and IL-17F nanobody sonelokimab: is there a role for IL-17F in disease reoccurrence?

[3] Helena Iznardo, et al. Ther Adv Chronic Dis. Dual inhibition of IL-17A and IL-17F in psoriatic disease

[4] Francesco Bellinato, et al. Biologics. Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules

Related IL Receptor/Related Products
Reslizumab

Reslizumab (Sch 55700) is a humanized monoclonal antibody targeting human interleukin 5 (IL-5) for the study of eosinophilic asthma. Reslizumab effectively blocks il-5 function. Reslizumab inhibited IL-5-dependent cell proliferation with an IC50 of about 91.1 pM.
Montelukast sodium

Montelukast sodium selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.
VGX-1027

VGX-1027 is an orally active immunomodulator.
Diacerein

Diacerin is an inhibitor of pro-inflammatory cytokine Interleukin-1B (IL-1B) production, prescribed for osteoarthritis and chronic inflammatory arthritis.
SC144

SC144 is the first oral active GP130 (IL6-beta) inhibitor. SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, eliminates Stat3 phosphorylation and nuclear translocation, and further inhibits downstream target gene expression. SC144 inhibited signal transduction induced by GP130 ligand. SC144 induces apoptosis of human ovarian cancer cells.
  Catalog
Abmole Inhibitor Catalog




Keywords: Sonelokimab, ALX 0761; M 1095 supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.


 
Get to Know Us
Customer Support
Resources
Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.